Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs)

Shang J, Ling X, Zhang L, Tang Y, Xiao Z, Cheng Y, et al. Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging. 2016;43:1945–53. doi: 10.1007/s00259-016-3420-7 .

Bazan JG, Duan F, Snyder BS, Horng D, Graves EE, Siegel BA, et al. Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235. Eur J Nucl Med Mol Imaging. 2017;44:17–24. doi: 10.1007/s00259-016-3520-4 .

Bazan JG, Koong AC, Kapp DS, Quon A, Graves EE, Loo Jr BW, et al. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal. J Nucl Med. 2013;54:27–32. doi: 10.2967/jnumed.112.109470 .

Gauthe M, Richard-Molard M, Fayard J, Alberini JL, Cacheux W, Lievre A. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer. Eur J Nucl Med Mol Imaging. 2017;44:63–70. doi: 10.1007/s00259-016-3475-5 .

Takeuchi S, Rohren EM, Abdel-Wahab R, Xiao L, Morris JS, Macapinlac HA, et al. Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers. Eur J Nucl Med Mol Imaging. 2016. doi: 10.1007/s00259-016-3583-2 .

van Baardwijk A, Bosmans G, Boersma L, Buijsen J, Wanders S, Hochstenbag M, et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys. 2007;68:771–8. doi: 10.1016/j.ijrobp.2006.12.067 .

Cheebsumon P, Boellaard R, de Ruysscher D, van Elmpt W, van Baardwijk A, Yaqub M, et al. Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology. EJNMMI Res. 2012;2:56. doi: 10.1186/2191-219x-2-56 .

Cheebsumon P, van Velden FH, Yaqub M, Frings V, de Langen AJ, Hoekstra OS, et al. Effects of image characteristics on performance of tumor delineation methods: a test-retest assessment. J Nucl Med. 2011;52:1550–8. doi: 10.2967/jnumed.111.088914 .

Cheebsumon P, Yaqub M, van Velden FH, Hoekstra OS, Lammertsma AA, Boellaard R. Impact of [(1)(8)F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology. Eur J Nucl Med Mol Imaging. 2011;38:2136–44. doi: 10.1007/s00259-011-1899-5 .

Mikhaeel NG, Smith D, Dunn JT, Phillips M, Moller H, Fields PA, et al. Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL. Eur J Nucl Med Mol Imaging. 2016;43:1209–19. doi: 10.1007/s00259-016-3315-7 .

Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255–68.

Lasnon C, Desmonts C, Quak E, Gervais R, Do P, Dubos-Arvis C, et al. Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients. Eur J Nucl Med Mol Imaging. 2013;40:985–96. doi: 10.1007/s00259-013-2391-1 .

Lasnon C, Salomon T, Desmonts C, Do P, Oulkhouir Y, Madelaine J, et al. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction. Ann Nucl Med. 2016. doi: 10.1007/s12149-016-1135-2 .

Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. Eur J Nucl Med Mol Imaging. 2015;42:2072–82. doi: 10.1007/s00259-015-3128-0 .

Quak E, Le Roux PY, Lasnon C, Robin P, Hofman MS, Bourhis D, et al. Does PET SUV harmonization impact PERCIST response classification? Journal of nuclear medicine : official publication. Soc Nucl Med. 2016. doi: 10.2967/jnumed.115.171983 .

Hanna GG, Hounsell AR, O'Sullivan JM. Geometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods. Clin Oncol (R Coll Radiol). 2010;22:515–25. doi: 10.1016/j.clon.2010.05.006 .

Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, et al. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur J Nucl Med Mol Imaging. 2015. doi: 10.1007/s00259-015-3165-8 .

Kadrmas DJ, Casey ME, Conti M, Jakoby BW, Lois C, Townsend DW. Impact of time-of-flight on PET tumor detection. J Nucl Med. 2009;50:1315–23. doi: 10.2967/jnumed.109.063016 .

Callahan J, Kron T, Schneider-Kolsky M, Dunn L, Thompson M, Siva S, et al. Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume. Int J Radiat Oncol Biol Phys. 2013;86:749–54. doi: 10.1016/j.ijrobp.2013.02.030 .

Geets X, Lee JA, Bol A, Lonneux M, Gregoire V. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging. 2007;34:1427–38. doi: 10.1007/s00259-006-0363-4 .

Dunn OJ. Multiple comparisons using rank sums. Technometrics. 1964;6:241–52. doi: 10.1080/00401706.1964.10490181 .

Bettinardi V, Presotto L, Rapisarda E, Picchio M, Gianolli L, Gilardi MC. Physical performance of the new hybrid PETCT Discovery-690. Med Phys. 2011;38:5394–411. doi: 10.1118/1.3635220 .

Kotasidis FA, Zaidi H. Experimental evaluation and basis function optimization of the spatially variant image-space PSF on the Ingenuity PET/MR scanner. Med Phys. 2014;41:062501. doi: 10.1118/1.4875689 .

Panin VY, Kehren F, Michel C, Casey M. Fully 3-D PET reconstruction with system matrix derived from point source measurements. IEEE Trans Med Imaging. 2006;25:907–21.

Nuyts J. Unconstrained image reconstruction with resolution modelling does not have a unique solution. EJNMMI Physics. 2014;1:98. doi: 10.1186/s40658-014-0098-4 .

Rogasch JM, Hofheinz F, Lougovski A, Furth C, Ruf J, Grosser OS, et al. The influence of different signal-to-background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time-of-flight reconstruction. EJNMMI Physics. 2014;1:12. doi: 10.1186/2197-7364-1-12 .

Zeng GL. Gibbs artifact reduction by nonnegativity constraint. J Nucl Med Technol. 2011;39:213–9. doi: 10.2967/jnmt.110.086439 .

Schaefer A, Kremp S, Hellwig D, Rube C, Kirsch CM, Nestle U. A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data. Eur J Nucl Med Mol Imaging. 2008;35:1989–99. doi: 10.1007/s00259-008-0875-1 .

Schaefer A, Nestle U, Kremp S, Hellwig D, Grgic A, Buchholz HG, et al. Multi-centre calibration of an adaptive thresholding method for PET-based delineation of tumour volumes in radiotherapy planning of lung cancer. Nuklearmedizin Nucl Med. 2012;51:101–10. doi: 10.3413/Nukmed-0452-11-12 .

Hatt M, Cheze Le Rest C, Albarghach N, Pradier O, Visvikis D. PET functional volume delineation: a robustness and repeatability study. Eur J Nucl Med Mol Imaging. 2011;38:663–72. doi: 10.1007/s00259-010-1688-6 .

Konert T, Vogel W, MacManus MP, Nestle U, Belderbos J, Gregoire V, et al. PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014. Radiother Oncol. 2015;116:27–34. doi: 10.1016/j.radonc.2015.03.014 .